SFX by Ex Libris Inc.

Title:	Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Source:	Nature [0028-0836] Barna, M yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Meyer, N. "MYC - TIMELINE Reflecting on 25 years with MYC." Nature reviews. Cancer 8.12 (2008): 976-990.
description	2.	Koh, Cheryl M. "MYC and prostate cancer." Genes & cancer 1.6 (2010): 617-628.
description	3.	Bilanges, B. "Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies." Oncogene 26.41 (2007): 5973-5990.
description	4.	Beltran, Himisha A. "Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity." European urology 63.5 (2012): 920-926.
description	5.	Clurman, B. "Defining tumour-suppressor genes." Nature 389.6647 (1997): 123-123.
description	6.	Khanna Gupta, A. "Regulation and deregulation of mRNA translation during myeloid maturation." Experimental hematology 39.2 (2011): 133-141.
description	7.	Hartl, M. "Stem cell-specific activation of an ancestral myc protooncogene with conserved basic functions in the early metazoan Hydra." Proceedings of the National Academy of Sciences of the United States of America 107.9 (2010): 4051-4056.
description	8.	Bora Gurel, B. "Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis." Modern pathology 21.9 (2008): 1156-1167.
description	9.	Hoffman, B. "Apoptotic signaling by c-MYC." Oncogene 27.50 (2008): 6462-6472.
description	10.	Jorgensen, P. "A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size." Genes & development 18.20 (2004): 2491-2505.
description	11.	Felsher, Dean W W. "Cancer revoked: oncogenes as therapeutic targets." Nature reviews. Cancer 3.5 (2003): 375-80.
description	12.	Adhikary, S. "Transcriptional regulation and transformation by Myc proteins." Nature reviews. Molecular cell biology 6.8 (2005): 635-45.
description	13.	Benitah, Salvador Aznar A. "MYC in mammalian epidermis: how can an oncogene stimulate differentiation?" Nature reviews. Cancer 8.3 (2008): 234-42.
description	14.	Watters, James W. "Developing gene expression signatures of pathway deregulation in tumors." Molecular cancer therapeutics 5.10 (2006): 2444-2449.
description	15.	Dillon, R L L. "The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer." Oncogene 26.9 (2007): 1338-45.
description	16.	Pelengaris, S. "c-MYC: more than just a matter of life and death." Nature reviews. Cancer 2.10 (2002): 764-76.
description	17.	Menon, R. "Somatic copy number alterations by whole exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer." The Journal of pathology 231.4 (2013): 505-16.
description	18.	Sudbery, P. "Cell biology. When wee meets whi." Science 297.5580 (2002): 351-2.
description	19.	Warner, J. "The economics of ribosome biosynthesis in yeast." Trends in biochemical sciences 24.11 (1999): 437-440.
description	20.	Nelson, C C C. "PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer." Oncogene 25.3 (2005): 329-337.